Research to revisit
An aging signature is an instrument, not a verdict
Aug 8, 2024 · Added Oct 7, 2026
The development
The 2024 proteomic aging study remains a useful entry point into biological risk measurement.
Our reading
Ask what a clock predicts, in whom, and whether intervention-driven changes have been validated.
The interpretation above is editorial analysis, not a claim made by the source.
Nature MedicineRisk prediction does not establish that changing this clock with a treatment improves health or extends life.
Read the evidence note